Clinical Trials Sponsored by Bheri Zonal Ayurveda Hospital
Total 1 results
-
Bheri Zonal Ayurveda HospitalCompleted
Sponsors and Collaborators
- Singapore Thong Chai Medical Institution
- Institute for Prostate Cancer Research (IPCR)
- Fatemeh Hoseinzadegan
- Medfield Diagnostics
- SAksoy
- Eastern Maine Medical Center
- MidAmerica Neuroscience Research Foundation at Rowe Neurology Institute
- Unimed Pharmaceuticals
- National Center of Blood Transfusion Mexico.
- IN2 Ltd.
- Institute for Advanced Laser Dentistry
- INSYS Therapeutics Inc
- The Metabolic Unit Research Fund, The Royal Hospitals, Belfast, Northern Ireland
- Laboratoires Thea
- Veterans 76 Ltd.
- Neomentum
- Balchem
- Perha Pharmaceuticals
- National Advisory Immunization Committee Indonesia
- California Retina Consultants
- View Full List
Medical Conditions
- AMD, ACEi's/ARB Prevent/Worsen Risk of COVID-19 Infection
- Liver Transplant Failure and Rejection
- Recurrent Adult Primary Liver Cancer
- Mild Cognitive Impairment Due to Alzheimer Disease
- Blow Out Fracture of Orbit
- Intraoral Pain Threshold
- Sodium-glucose Co-transporter-2 Inhibitor
- Alpha1-Antitrypsin Deficiency
- Pelviureteric Junction Obstruction
- Age-Related (Dry) Macular Degeneration
- Head Trauma,Closed
- Smoking, Tobacco
- No Other Cause for Chronic Kneearthritis
- Anxiety Levels
- Drug Related Sleep Disturbance
- Hospital-Acquired Pneumonia
- Cerebral Embolization During TAVI Using Balloon-expandable vs. Self-expandable Valves
- Psychological and Behavioral Symptoms
- SACROILIAC JOINT DYSFUNCTION
- Small Intestine Obstruction
- View Full List
Drug Interventions
- Period 2 - Visit 1 Warm Control vehicle, Visit 2 Warm Glucagon, Visit 3 Cold control
- Amoxicillin
- Caudal Block Anesthesia
- Fecal Microbiota Transplant (FMT)
- AstroStem-V
- Ranirestat
- Raltitrexed plus Docetaxel
- Nab paclitaxel
- Denosumab Injection
- ATI-501 400mg BID (Low dose)
- Tretinoin liposome
- Fulvestrant
- Recombinant human Epidermal Growth Factor (rhEGF)
- AGN-CognI.Q
- Chidamide
- Ofatumumab
- Antitumor B
- XMT-1536 (Upifitamab Rilsodotin)
- Part B: TRV250 Dose 3
- Olodaterol hydrochloride 2.5mcg, tiotropium bromide 2.5mcg
- View Full List
CROs by country
- Contract Research Organizations in Azerbaijan
- Contract Research Organizations in Belgium
- Contract Research Organizations in Congo, DR of
- Contract Research Organizations in Djibouti
- Contract Research Organizations in Georgia
- Contract Research Organizations in Guinea
- Contract Research Organizations in Indonesia
- Contract Research Organizations in Ireland
- Contract Research Organizations in Japan
- Contract Research Organizations in Kuwait
- Contract Research Organizations in Mongolia
- Contract Research Organizations in Saint Lucia
- Contract Research Organizations in Zambia
- CRO list by country